It will come as no surprise to Breitbart News readers that Facebook’s vaunted fact-checking system does not stop, or even appropriately label, fake, misleading claims from the left-wing media about President Donald Trump.
A story from Verizon-owned HuffPost claims that the president has a stake in a drug company that produces hydroxycholoroquine, the drug being promoted by himself and many in the administration as a potential treatment for the Chinese virus. The article is currently on Facebook without any labels alerting users that the information is false or even just misleading.
This is despite the fact that Snopes, a left-leaning fact-checker that until February 2019 was one of Facebook’s fact-checking partners, has rated the claim that Trump benefits financially from promoting hydroxychloroquine as “mostly false.”
Although Snopes eventually caught up, its fact check trailed Breitbart News’s. As Economics Editor John Carney explained several hours before Snopes:
The report cited by the HuffPost is from a New York Times story that said: “Trump himself has a small personal financial interest in Sanofi, the French drugmaker that makes Plaquenil, the brand-name version of hydroxychloroquine.”
Trump’s personal financial interest, however, does not include a stake in Sanofi–and the New York Times did not claim it did. Instead, Trump’s financial disclosures show that his three family trusts each had investments in a $10.3 billion Dodge & Cox mutual fund that owns shares in Sanofi, the world’s fifth-largest drugmaker by prescription sales. As of its latest disclosures, those holdings amount to just 3.3 percent of the fund’s holdings.
Trump’s most recent financial disclosure forms lists holdings in the Dodge & Cox International Fund valued between $1,001 and $15,000. That means Trump holds a maximum stake in the mutual funds of $45,000, giving him an indirect interest in Sanofi of $1,485 at the most.
His “financial interest” in Sanofi, which has a market capitalization of nearly $58 billion, could be as low as $99.10. – READ MORE
Listen to the insightful Thomas Paine Podcast Below --